Seeds of Transformation

Seeds of Transformation

Share this post

Seeds of Transformation
Seeds of Transformation
Ozempic Briefing for CPG Brands - the 6 Seeds Sustenance

Ozempic Briefing for CPG Brands - the 6 Seeds Sustenance

How are weightloss drugs impacting CPG products?

Jul 08, 2024
∙ Paid
1

Share this post

Seeds of Transformation
Seeds of Transformation
Ozempic Briefing for CPG Brands - the 6 Seeds Sustenance
Share


Novo Nordisk, makers of Ozempic and Wegovy is seeing growth of up to 27% in 2024 driven by soaring demand. Ozempic itself saw a 52% sales increase in 2024 while the obesity drug segment containing Wegovy grew by a staggering 154%.

As the use of weight loss medications like Ozempic becomes more prevalent, CPG companies are already stepping up to meet the …

Keep reading with a 7-day free trial

Subscribe to Seeds of Transformation to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Andreas Duess
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share